Skip to content

Clinical and neuroimaging features of patients with claustrum sign.

Chunyan Zhao, Meijiao Zhang, Qingping Zhang, Xinhua Bao

Frontiers in neurology January 1, 2025 DOI: 10.3389/fneur.2025.1589940 via PubMed

Summary

AI-generated from the abstract

Among 20 patients with the claustrum sign on brain MRI, febrile infection-related epilepsy syndrome (FIRES) was the most common diagnosis (60%), followed by antibody-negative autoimmune encephalitis (20%), myelin oligodendrocyte glycoprotein antibody-associated disease (15%), and Wilson's disease (5%). Seizures occurred in 85% and impaired consciousness in 70%. The claustrum sign appeared a median of 11.5 days after symptom onset, was transient in most cases, and resolved by a median of 53 days. Patients with FIRES had the worst outcomes—all developed chronic epilepsy, 75% had poor memory and calculation—while those with autoimmune encephalitis or MOGAD had favorable outcomes. The claustrum sign likely represents a transient neuroinflammatory lesion and may be an imaging marker of neuroinflammation, with lesions potentially contributing to seizures and impaired consciousness through disrupted connectivity.

Study at a glance

Characteristics Retrospective cohort study Peer reviewed
Sample size 20
Population Patients with claustrum sign on MRI
Duration Follow-up MRIs up to day 132
Keywords Wilson’s disease Autoimmune encephalitis Claustrum sign Consciousness Neuroinflammation
Citations 2
Key finding The claustrum sign is a transient neuroinflammatory imaging marker most commonly associated with FIRES, and long-term outcomes depend on the underlying disease.

Abstract

This study aimed at summarizing the clinical and neuroimaging features of patients with claustrum sign, so as to enhance the understanding of this imaging feature and explore its clinical significance. Clinical data from 20 patients with claustrum sign were collected. The clinical characteristics, neuroimaging evolution, and outcomes were analyzed. This cohort included 14 males and 6 females and the median age of onset was 6 years old. Diagnoses included febrile infection-related epilepsy syndrome (FIRES) in 12 cases (60%), antibody-negative autoimmune encephalitis (AbNAE) in 4 (20%), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in 3 (15%), and Wilson's disease (WD) in 1 (5%). Predominant neurological symptoms included seizures (85%) and impaired consciousness (70%). The claustrum sign was observed on days 1-25 (median: day 11.5) after the onset of neurologic symptoms. It presented on the first MRI between days 1 and 14 (median: day 5.5) in 8 cases (40%), while it was absent on the first MRI (days 1-7, median: day 3) in the remaining 12 cases (60%) and appeared on the repeated MRIs (days 6-25, median: day 15). On the follow-up MRIs in 19 cases, the claustrum sign resolved on days 16-132 (median: day 53) in 17 patients, except one with AbNAE and one with WD. The patients with FIRES had the worst prognosis, all developed chronic epilepsy, 75% showed poor memory and calculation, and the median Pediatric Cerebral Performance Category (PCPC) score was 3. In contrast, patients with AbNAE and MOGAD had favorable outcomes with a median PCPC score of 1, respectively. The claustrum sign may represent a transient neuroinflammatory lesion and serve as an imaging marker of neuroinflammation. Lesions in the claustrum can lead to dysfunction of its connected regions, which could be one of the potential mechanisms underlying the high incidence of seizures and the impaired consciousness in children with this imaging feature. Long-term outcomes are closely related to the primary disease.

Comments

No comments yet.

Log in to comment